Wall Street Breakfast Podcast: Fewer EV Models Qualify For Full Tax Credit [Seeking Alpha]
Corcept Therapeutics Incorporated (CORT)
Last corcept therapeutics incorporated earnings: 2/20 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
corcept.com/investors
Company Research
Source: Seeking Alpha
Bitcoin surpasses $45,000 for the first time in two years, driven by anticipation of US approval of a spot Bitcoin ETF. Corcept Therapeutics plunges after losing a patent lawsuit against Teva Pharmaceuticals over a drug for Cushing's syndrome. Listen below or on the go on Apple Podcasts and Spotify 2024 electric vehicle jolt - fewer models qualify for the full tax credit. (00:33) Bitcoin ( BTC-USD ) rings in the new year with a rise above $45,000. (02:10) Corcept Therapeutics ( CORT ) plunges after loss in patent battle with Teva ( TEVA This is an abridged transcript of the podcast. Now that we're in 2024, the number of electric vehicle models eligible for the $7,500 consumer tax credit in the U.S. has fallen. The number of EV models that qualified for the EV tax credit on December 31 under the old criteria was 25 but today that number is 13 . This is due to tighter rules around sourcing parts from Chinese suppliers. The new rules specifically exclude from the tax credi
Show less
Read more
Impact Snapshot
Event Time:
CORT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CORT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CORT alerts
High impacting Corcept Therapeutics Incorporated news events
Weekly update
A roundup of the hottest topics
CORT
News
- Corcept Completes Enrollment in Phase 4 CATALYST Trial [Yahoo! Finance]Yahoo! Finance
- Corcept Completes Enrollment in Phase 4 CATALYST TrialGlobeNewswire
- Levi & Korsinsky, LLP Notifies Shareholders of Corcept Therapeutics Incorporated (CORT) an Upcoming Claims Deadline in a Class Action SettlementAccesswire
- Corcept Therapeutics Incorporated (NASDAQ: CORT) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.MarketBeat
- Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference CallGlobeNewswire
CORT
Earnings
- 2/15/24 - Beat
CORT
Analyst Actions
- 4/23/24 - HC Wainwright
CORT
Sec Filings
- 4/18/24 - Form DEFA14A
- 4/17/24 - Form ARS
- 4/17/24 - Form 8-K
- CORT's page on the SEC website